NCT00160420View on ClinicalTrials.gov

A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2004

Study Completion Date

July 31, 2004

Conditions
Endometriosis
Interventions
DRUG

Asoprisnil

5mg Tablet, oral Daily for 12 months

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00160420 - A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398 | Biotech Hunter | Biotech Hunter